Kineta has found a new home for deals with Genentech and Merck & Co. Tidying up the portfolio ahead of its merger with TuHURA ...

Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...

Becton Dickinson & Co. said it’s planning to separate part of its life sciences segment in a move aimed at raising the medical technology company’s stock.

Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...

Investors hammered Merck stock Tuesday after the company beat fourth-quarter expectations, but delivered a light 2025 outlook.

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

We recently published a list of Top 10 Best Dividend Stocks on Robinhood. In this article, we are going to take a look at ...

Christian Lacroix, Kapital, Laura Ashley, Stella McCartney, True Religion, Urban Skin RX, Vera Wang, and Vince have new ...

Harold’s financial expertise and leadership in scaling up high-growth, healthcare companies are an invaluable addition to Aspargo as we enter this transformative period,” said Michael Demurjian, CEO ...

Company denies downplaying risks of blockbuster Gardasil drug RFK Jr. set to earn fees for referring patients who sued Merck Merck & Co. is facing its first jury trial over claims the company ...

Merck (NSE:PROR) & Co., Inc. (NYSE ... network via organic expansions and acquisitions and has been on a mergers and acquisitions (M&A) binge in recent years. In 2023, it bought Magellan Midstream ...

According to the release, an overwhelming majority of shareholders were in favour of the merger. Myer reported that 96.16% of votes were approved the combination, with only 3.84% voting against it.